3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Uterine Cervical Neoplasms
18
Endometrial Neoplasms
4
Prostatic Neoplasms
3
Sarcoma
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Esophageal Neoplasms
2
Endometrial Clear Cell Adenocarcinoma
2
Vaginal Neoplasms
1
Uveitis
1
Uveal Melanoma
1
Squamous Cell Carcinoma of Head and Neck
1
Salivary Gland Neoplasms
1
Radiation Injuries
1
Obesity
1
Neurotoxicity Syndromes
1
Neoplasms, Unknown Primary
1
Malignant mesenchymal tumor
1
Lung Neoplasms
1
Locally Advanced Cervical Cancer
1
Locally Advanced Cervical Adenocarcinoma
1
Liver Neoplasms
1
Liposarcoma
1
Hyperthermia
1
Hemangiosarcoma
1
Hemangiopericytoma, Malignant
1
Head and Neck Neoplasms
1
Fibrosarcoma
1
Fatigue
1
Esophageal Squamous Cell Carcinoma
1
Interventions
Cisplatin
3
durvalumab
1
Sodium Chloride
1
Gemcitabine
1
Carboplatin
1
Brachytherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Locally Advanced Cervical Cancer
×
Brachytherapy
×
Clear all
NCT03830866
2024-07-26
CALLA
AstraZeneca
Phase 3
Completed
770 enrolled
12 charts